These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 2480424)

  • 1. Alpha-fetoprotein in the management of germ cell tumors of the ovary.
    Bonazzi C; Colombo N; Lissoni A; Pittelli MR; Bini S; Mangioni C
    J Nucl Med Allied Sci; 1989; 33(3 Suppl):53-8. PubMed ID: 2480424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current management of malignant germ cell tumor of the ovary.
    Aziz MF
    Gan To Kagaku Ryoho; 1995 Aug; 22 Suppl 3():262-76. PubMed ID: 7661594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is there a role for second-look laparotomy in the management of malignant germ cell tumors of the ovary? Experience at Institut Gustave Roussy.
    Culine S; Lhomme C; Michel G; Leclere J; Duvillard P; Droz JP
    J Surg Oncol; 1996 May; 62(1):40-5. PubMed ID: 8618400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment outcome of children and adolescents with germ cell tumor after combined therapy---a report of 44 cases].
    Sun XF; Yang QY; Zhen ZJ; Xia Y; Huang ZH; Ling JY
    Ai Zheng; 2006 Dec; 25(12):1529-32. PubMed ID: 17166380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cisplatin, vinblastine, and bleomycin combination chemotherapy in a stage IV pure endodermal sinus tumor of the ovary--a case report of a long-term survival].
    Saito N; Kashimura Y; Soh T; Tsukamoto N
    Gan No Rinsho; 1988 Dec; 34(15):2114-8. PubMed ID: 2466134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination chemotherapy in the management of ovarian germ cell malignancies.
    Schwartz PE
    Obstet Gynecol; 1984 Oct; 64(4):564-72. PubMed ID: 6207473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of elevated preoperative alpha-fetoprotein in postchemotherapy residual tumor resection for the disseminated germ cell tumors.
    Kobayashi T; Kawakita M; Terachi T; Habuchi T; Ogawa O; Kamoto T
    J Surg Oncol; 2006 Dec; 94(7):619-23. PubMed ID: 17111392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Characteristics of rare ovarian tumors--possibilities of organ preservation].
    Grischke EM; Wallwiener D; Bastert G
    Zentralbl Gynakol; 1996; 118(6):322-5. PubMed ID: 8768007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant mixed germ cell tumors of the ovary. A clinical and pathologic analysis of 30 cases.
    Kurman RJ; Norris HJ
    Obstet Gynecol; 1976 Nov; 48(5):579-89. PubMed ID: 185553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second-look laparotomy in endodermal sinus tumor: a report of two patients with normal levels of alpha-fetoprotein and residual tumor at reexploration.
    Curtin JP; Rubin SC; Hoskins WJ; Hakes TB; Lewis JL
    Obstet Gynecol; 1989 May; 73(5 Pt 2):893-5. PubMed ID: 2468119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The prognostic significance of serum alpha 1-fetoprotein in children and adolescents with malignant extracranial non-testicular germ cell tumors].
    Calaminus G; Vesterling-Hörner D; Bökkerink JP; Gadner H; Günther G; Haas HJ; Jürgens H; Teske C; Göbel U
    Klin Padiatr; 1991; 203(4):246-50. PubMed ID: 1719268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-fetoprotein production by a malignant mixed Müllerian tumor of the ovary.
    Rebischung C; Pautier P; Morice P; Lhomme C; Duvillard P
    Gynecol Oncol; 2000 Apr; 77(1):203-5. PubMed ID: 10739713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The significance of alpha-fetoprotein in the serum of patients with malignant teratomas and related gonadal neoplasms.
    Ballas M
    Ann Clin Lab Sci; 1974; 4(4):267-75. PubMed ID: 4142543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical management of malignant ovarian germ-cell tumors: 10 years' experience of 129 patients.
    Peccatori F; Bonazzi C; Chiari S; Landoni F; Colombo N; Mangioni C
    Obstet Gynecol; 1995 Sep; 86(3):367-72. PubMed ID: 7651644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum tumor marker half-life during chemotherapy allows early prediction of complete response and survival in nonseminomatous germ cell tumors.
    Toner GC; Geller NL; Tan C; Nisselbaum J; Bosl GJ
    Cancer Res; 1990 Sep; 50(18):5904-10. PubMed ID: 1697503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mixed germ cell tumors of the ovary.
    Gershenson DM; Del Junco G; Copeland LJ; Rutledge FN
    Obstet Gynecol; 1984 Aug; 64(2):200-6. PubMed ID: 6204258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pure ovarian immature teratoma, a unique and curable disease: 10 years' experience of 32 prospectively treated patients.
    Bonazzi C; Peccatori F; Colombo N; Lucchini V; Cantù MG; Mangioni C
    Obstet Gynecol; 1994 Oct; 84(4):598-604. PubMed ID: 7522313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nondysgerminomatous ovarian tumors: clinical characteristics, treatment, and outcome. A case-controlled study.
    Ghaemmaghami F; Hasanzadeh M; Karimi Zarchi M; Fallahi A
    Int J Surg; 2008 Oct; 6(5):382-6. PubMed ID: 18715834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Modified VAB-3 combination chemotherapy of stage IV endodermal sinus tumor of the ovary].
    Tsukamoto N; Imachi M; Sumioki H; Kamura T
    Gan To Kagaku Ryoho; 1984 Apr; 11(4):948-51. PubMed ID: 6202244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laparotomy for post chemotherapy residue in ovarian germ cell tumors.
    Mathew GK; Singh SS; Swaminathan RG; Tenali SG
    J Postgrad Med; 2006; 52(4):262-5. PubMed ID: 17102543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.